Kalpaklıoğlu, Ayşe FüsunKara, TürkanKurtipek, ErcanKoçyiğit, PınarEkici, AydanurEkici, Mehmet2020-06-252020-06-252005closedAccess1081-12061534-4436https://doi.org/10.1016/S1081-1206(10)61137-4https://hdl.handle.net/20.500.12587/3506Ekici, Arif B/0000-0001-6099-7066Background: Chronic cough is a common condition that has a significant impact on health-related quality of life (HRQoL). Objective: To investigate whether chronic cough is associated with adverse psychological and physical effects on quality of life (QoL) using different HRQoL questionnaires. Methods: Forty patients were recruited for the study. The diagnostic workup was mainly based on the pathogenic triad in chronic cough: postnasal drip syndrome, asthma, and gastroesophageal reflux disease. The HRQoL was evaluated with the cough-specific quality-of-life questionnaire (CQLQ), Leicester Cough Questionnaire (LCQ), Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36), and Hospital Anxiety and Depression Scale. Results: Symptom scores were significantly correlated with the CQLQ and LCQ (beta =.415 and beta = -.272, respectively) but not with the SF-36. A statistically significant difference was found in all questionnaires, except the physical component summary domain of the SF-36, after specific therapy. Correlation between the 2 specific HRQoL questionnaires was moderate to high when pretreatment and posttreatment scores were compared (r = -0.42 and r = -0.60). Concurrent validity of the LCQ was higher than the CQLQ when compared with the SF-36 domains. The effect size of each specific QoL questionnaire was I or higher after treatment, whereas it was much less in the SF-36. There was no change in depression with treatment despite anxiety. Posttreatment symptom scores were related with anxiety (r > 0.40) Conclusions: Because HRQoL is important to patients, a cough-specific HRQoL instrument, either the CQLQ or LCQ, should be routinely used to optimally evaluate the impact of cough on patients and to evaluate the efficacy of cough-modifying agents. Ann Allergy Asthma Immunol. 2005;94:581-585.eninfo:eu-repo/semantics/closedAccessArticle94558158510.1016/S1081-1206(10)61137-42-s2.0-1904436648115945562Q1WOS:000229400900014Q2